Premium
Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one‐stage assay
Author(s) -
Ghosh K.,
Shetty S.,
Mohanty D.
Publication year - 2001
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2001.00455.x
Subject(s) - medicine , haemophilia b , compound heterozygosity , factor v , haemophilia , antithrombin , gastroenterology , stage (stratigraphy) , protein s , protein c , haemophilia a , pediatrics , immunology , mutation , thrombosis , genetics , gene , heparin , paleontology , biology
During the course of investigations we encountered 11 patients with haemophilia A who had severe factor VIII deficiency as measured by one‐stage assay but had surprisingly mild clinical presentation. Four of these patients had either a brother, nephew or maternal uncle with severe clinical manifestations. Two patients had low protein S levels, and one was heterozygous for the factor V Leiden mutation. One patient had a combined deficiency of protein C and antithrombin III. Four patients had a two‐stage factor VIII assay value that was much higher than the one‐stage assay value. Five patients were heterozygous for the MTHFR gene C677T polymorphism, of whom two patients were also deficient for protein S and one had two‐stage factor assay values higher than the one‐stage assay values. The patient who was both factor VIII deficient and heterozygous for factor V Leiden had mild clinical presentation as compared to his maternal uncle who was only factor‐VIII deficient. The maternal cousin of the same patient was heterozygous for factor V Leiden and had suffered two thrombotic episodes. Thus, the present study advocates that the physiological inhibitors of blood coagulation also play an important role in cases of haemophilia A in the final outcome of haemostasis in vivo .